Embecta (EMBC) Liabilities and Shareholders Equity (2021 - 2026)

Embecta (EMBC) reported Liabilities and Shareholders Equity of $1.0 billion for Q1 2026, down 8.11% on a YoY basis from $1.1 billion in Q1 2025, and down 3.23% sequentially from $1.1 billion in Q4 2025.

Embecta (EMBC) Liabilities and Shareholders Equity (2021 - 2026) Analysis & Trends

Embecta (EMBC) has 6 years of Liabilities and Shareholders Equity data on file, last reported at $1.0 billion in Q1 2026.

  • For the quarter ending Q1 2026, Liabilities and Shareholders Equity fell 8.11% year-over-year to $1.0 billion; the trailing twelve-month figure through Mar 2026 stood at $4.3 billion (down 9.98% YoY), and the FY2025 full-year result was $1.1 billion, down 15.12% from the prior year.
  • Liabilities and Shareholders Equity declined to $1.0 billion in Q1 2026, from $1.1 billion in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $1.3 billion in Q3 2024 to a low of $833.5 million in Q1 2022.
  • A 5-year average of $1.1 billion and a median of $1.2 billion in 2025 frame the typical range for Liabilities and Shareholders Equity.
  • Across the five-year window, Liabilities and Shareholders Equity surged 61.77% in 2022 and fell 15.12% in 2025, its largest moves.
  • Tracing EMBC's Liabilities and Shareholders Equity over 5 years: stood at $1.2 billion in 2022, then grew by 1.75% to $1.2 billion in 2023, then decreased by 5.61% to $1.1 billion in 2024, then dropped by 7.46% to $1.1 billion in 2025, then fell by 3.23% to $1.0 billion in 2026.
  • Business Quant data shows EMBC's Liabilities and Shareholders Equity at $1.0 billion in Q1 2026, $1.1 billion in Q4 2025, and $1.1 billion in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Alcon 32,734,969.19 Bn 32,734,967.53 Bn 1.53 Bn 31.62 Bn
2 Intuitive Surgical 117.50 Bn 112.41 Bn 1.96 Bn 20.88 Bn
3 Becton Dickinson 42.93 Bn 42.11 Bn 2.15 Bn 50.83 Bn
4 Medline 30.82 Bn 36.66 Bn 1.84 Bn 39.01 Bn
5 Resmed 27.90 Bn 26.23 Bn 890.98 Mn 8.78 Bn
6 West Pharmaceutical Services 26.76 Bn 26.23 Bn 329.20 Mn 4.08 Bn
7 Cooper Companies 15.30 Bn 15.16 Bn 735.40 Mn 12.48 Bn
8 Solventum 13.46 Bn 12.90 Bn 1.10 Bn 14.10 Bn
9 Align Technology 12.02 Bn 10.96 Bn 736.59 Mn 6.31 Bn
10 Embecta 192.72 Mn -678,250.00 127.80 Mn 1.03 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.03 Bn
Dec 31, 2025 1.06 Bn
Sep 30, 2025 1.09 Bn
Jun 30, 2025 1.16 Bn
Mar 31, 2025 1.12 Bn
Dec 31, 2024 1.15 Bn
Sep 30, 2024 1.29 Bn
Jun 30, 2024 1.27 Bn
Mar 31, 2024 1.20 Bn
Dec 31, 2023 1.22 Bn
Sep 30, 2023 1.21 Bn
Jun 30, 2023 1.25 Bn
Mar 31, 2023 1.21 Bn
Dec 31, 2022 1.20 Bn
Sep 30, 2022 1.09 Bn
Jun 30, 2022 1.05 Bn
Mar 31, 2022 833.50 Mn
Dec 31, 2021 739.90 Mn
Sep 30, 2021 788.00 Mn